Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 72

Similar articles for PubMed (Select 22437938)

1.

Coordinated regulation of myeloid cells by tumours.

Gabrilovich DI, Ostrand-Rosenberg S, Bronte V.

Nat Rev Immunol. 2012 Mar 22;12(4):253-68. doi: 10.1038/nri3175. Review.

2.

Myeloid cells and the microenvironment, microorganisms and metabolism.

Bogdan C, Steinkasserer A.

Immunobiology. 2015 Feb;220(2):iii. doi: 10.1016/S0171-2985(14)00268-X. No abstract available.

PMID:
25499734
3.

Innate immune cell collaborations instigate transplant tolerance.

Ochando JC, Turnquist HR.

Am J Transplant. 2014 Nov;14(11):2441-3. doi: 10.1111/ajt.12912. Epub 2014 Oct 13. No abstract available.

PMID:
25311574
4.

Impact of myeloid cells on the efficacy of anticancer chemotherapy.

Senovilla L, Aranda F, Galluzzi L, Kroemer G.

Curr Opin Immunol. 2014 Oct;30:24-31. doi: 10.1016/j.coi.2014.05.009. Epub 2014 Jun 18. Review.

PMID:
24950501
5.

Are macrophages, myeloid derived suppressor cells and neutrophils mediators of local suppression in healthy and cancerous tissues in aging hosts?

Jackaman C, Nelson DJ.

Exp Gerontol. 2014 Jun;54:53-7. doi: 10.1016/j.exger.2013.11.009. Epub 2013 Nov 28. Review.

PMID:
24291067
6.

Tumour-associated macrophages and cancer.

Cook J, Hagemann T.

Curr Opin Pharmacol. 2013 Aug;13(4):595-601. doi: 10.1016/j.coph.2013.05.017. Epub 2013 Jun 15. Review.

PMID:
23773801
7.

Collaborating with the enemy: function of macrophages in the development of neoplastic disease.

Eljaszewicz A, Wiese M, Helmin-Basa A, Jankowski M, Gackowska L, Kubiszewska I, Kaszewski W, Michalkiewicz J, Zegarski W.

Mediators Inflamm. 2013;2013:831387. doi: 10.1155/2013/831387. Epub 2013 Mar 17. Review.

8.

Flagellin induces myeloid-derived suppressor cells: implications for Pseudomonas aeruginosa infection in cystic fibrosis lung disease.

Rieber N, Brand A, Hector A, Graepler-Mainka U, Ost M, Schäfer I, Wecker I, Neri D, Wirth A, Mays L, Zundel S, Fuchs J, Handgretinger R, Stern M, Hogardt M, Döring G, Riethmüller J, Kormann M, Hartl D.

J Immunol. 2013 Feb 1;190(3):1276-84. doi: 10.4049/jimmunol.1202144. Epub 2012 Dec 31.

9.

Human plasmacytoid dendritic cells efficiently cross-present exogenous Ags to CD8+ T cells despite lower Ag uptake than myeloid dendritic cell subsets.

Tel J, Schreibelt G, Sittig SP, Mathan TS, Buschow SI, Cruz LJ, Lambeck AJ, Figdor CG, de Vries IJ.

Blood. 2013 Jan 17;121(3):459-67. doi: 10.1182/blood-2012-06-435644. Epub 2012 Dec 4.

10.

Host indoleamine 2,3-dioxygenase: contribution to systemic acquired tumor tolerance.

Johnson TS, Munn DH.

Immunol Invest. 2012;41(6-7):765-97. doi: 10.3109/08820139.2012.689405. Review.

PMID:
23017145
11.

Myeloid cells in tumour-immune interactions.

Kareva I, Berezovskaya F, Castillo-Chavez C.

J Biol Dyn. 2010 Jul;4(4):315-27. doi: 10.1080/17513750903261281.

PMID:
22881128
12.

Regulatory immune cells in transplantation.

Wood KJ, Bushell A, Hester J.

Nat Rev Immunol. 2012 May 25;12(6):417-30. doi: 10.1038/nri3227. Review.

PMID:
22627860
13.

NFAT control of innate immunity.

Fric J, Zelante T, Wong AY, Mertes A, Yu HB, Ricciardi-Castagnoli P.

Blood. 2012 Aug 16;120(7):1380-9. doi: 10.1182/blood-2012-02-404475. Epub 2012 May 18. Review.

14.

Amino acid metabolism related to immune tolerance by MDSCs.

Yang B, Wang X, Ren X.

Int Rev Immunol. 2012 Jun;31(3):177-83. doi: 10.3109/08830185.2012.679989. Review.

PMID:
22587019
15.

Cyclophosphamide-induced myeloid-derived suppressor cell population is immunosuppressive but not identical to myeloid-derived suppressor cells induced by growing TC-1 tumors.

Mikyšková R, Indrová M, Polláková V, Bieblová J, Símová J, Reiniš M.

J Immunother. 2012 Jun;35(5):374-84. doi: 10.1097/CJI.0b013e318255585a.

PMID:
22576342
16.

Tumour immunotherapy--leukocytes take up the fight.

Alderton GK, Bordon Y.

Nat Rev Immunol. 2012 Apr;12(4):237.

PMID:
22545289
17.

Immunology in the clinic review series; focus on cancer: tumour-associated macrophages: undisputed stars of the inflammatory tumour microenvironment.

Allavena P, Mantovani A.

Clin Exp Immunol. 2012 Feb;167(2):195-205. doi: 10.1111/j.1365-2249.2011.04515.x. Review.

18.

Role of myeloid-derived suppressor cells in tumor immunotherapy.

Martin F, Apetoh L, Ghiringhelli F.

Immunotherapy. 2012 Jan;4(1):43-57. doi: 10.2217/imt.11.154. Review.

PMID:
22150000
19.

Phenotype, function and clinical implications of myeloid-derived suppressor cells in cancer patients.

Filipazzi P, Huber V, Rivoltini L.

Cancer Immunol Immunother. 2012 Feb;61(2):255-63. doi: 10.1007/s00262-011-1161-9. Epub 2011 Nov 27. Review.

PMID:
22120756
20.

CD15+/CD16low human granulocytes from terminal cancer patients: granulocytic myeloid-derived suppressor cells that have suppressive function.

Choi J, Suh B, Ahn YO, Kim TM, Lee JO, Lee SH, Heo DS.

Tumour Biol. 2012 Feb;33(1):121-9. doi: 10.1007/s13277-011-0254-6. Epub 2011 Nov 13.

PMID:
22081309
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk